Fieldpoint Private Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $15K | Sell |
25
-29
| -54% | -$17.4K | ﹤0.01% | 657 |
|
|
2022
Q1 | $38K | Buy |
54
+5
| +10% | +$3.52K | 0.01% | 661 |
|
|
2021
Q4 | $31K | Buy |
49
+15
| +44% | +$9.49K | 0.01% | 741 |
|
|
2021
Q3 | $21K | Buy |
34
+4
| +13% | +$2.47K | ﹤0.01% | 810 |
|
|
2021
Q2 | $18K | Sell |
30
-70
| -70% | -$42K | ﹤0.01% | 848 |
|
|
2021
Q1 | $47K | Sell |
100
-406
| -80% | -$191K | 0.01% | 588 |
|
|
2020
Q4 | $244K | Buy |
506
+25
| +5% | +$12.1K | 0.06% | 259 |
|
|
2020
Q3 | $269K | Sell |
481
-119
| -20% | -$66.6K | 0.08% | 239 |
|
|
2020
Q2 | $374K | Buy |
600
+118
| +24% | +$73.6K | 0.13% | 168 |
|
|
2020
Q1 | $235K | Sell |
482
-213
| -31% | -$104K | 0.09% | 212 |
|
|
2019
Q4 | $261K | Sell |
695
-19
| -3% | -$7.14K | 0.08% | 233 |
|
|
2019
Q3 | $198K | Sell |
714
-51
| -7% | -$14.1K | 0.07% | 213 |
|
|
2019
Q2 | $239K | Buy |
765
+384
| +101% | +$120K | 0.07% | 207 |
|
|
2019
Q1 | $156K | Buy |
381
+28
| +8% | +$11.5K | 0.06% | 213 |
|
|
2018
Q4 | $132K | Sell |
353
-98
| -22% | -$36.6K | 0.06% | 220 |
|
|
2018
Q3 | $182K | Sell |
451
-155
| -26% | -$62.6K | 0.07% | 211 |
|
|
2018
Q2 | $209K | Buy |
606
+25
| +4% | +$8.62K | 0.08% | 203 |
|
|
2018
Q1 | $200K | Sell |
581
-208
| -26% | -$71.6K | 0.09% | 170 |
|
|
2017
Q4 | $297K | Sell |
789
-232
| -23% | -$87.3K | 0.16% | 131 |
|
|
2017
Q3 | $457K | Buy |
1,021
+756
| +285% | +$338K | 0.2% | 122 |
|
|
2017
Q2 | $130K | Buy |
+265
| New | +$130K | 0.09% | 79 |
|